Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left ventricular diastolic function in hypertrophic cardiomyopathy.

R O Bonow1

  • 1Cardiology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Herz
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New oral anticoagulants and regional anaesthesia.

British journal of anaesthesia·2013
Same author

Initial clinical experience with Myxo-ETlogix mitral valve repair ring.

The Journal of thoracic and cardiovascular surgery·2008
Same author

Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study.

Heart (British Cardiac Society)·2007
Same author

Polymorphisms in adenosine receptor genes are associated with infarct size in patients with ischemic cardiomyopathy.

Clinical pharmacology and therapeutics·2007
Same author

Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve.

Heart (British Cardiac Society)·2005

Impaired diastolic function in hypertrophic cardiomyopathy affects left ventricular filling and can cause symptoms like dyspnea. Calcium channel blockers, particularly verapamil, show promise in improving relaxation and filling dynamics.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is characterized by impaired left ventricular (LV) diastolic function due to hypertrophy and stiffness.
  • This dysfunction leads to altered LV filling, reduced distensibility, increased LV filling pressures, and coronary microcirculation compression.

Purpose of the Study:

  • To explore the mechanisms underlying impaired LV diastolic function in HCM.
  • To evaluate the impact of calcium channel blockers on LV diastolic function and filling in HCM patients.

Main Methods:

  • The study reviews factors affecting passive elastic properties and active relaxation of the LV in HCM.
  • It discusses inactivation-dependent and load-dependent mechanisms of impaired relaxation.
  • The effects of calcium channel blockers (verapamil, diltiazem, nifedipine) on LV function were examined.

Related Experiment Videos

Main Results:

  • Reduced LV distensibility contributes to symptoms such as fatigue, dyspnea, and angina.
  • Impaired relaxation involves increased intracellular calcium and prolonged contractile protein interaction, alongside potential myocardial ischemia.
  • Calcium channel blockers favorably influence LV relaxation and filling; verapamil improves stroke volume without increasing end-diastolic pressure.

Conclusions:

  • Impaired diastolic function is central to HCM pathophysiology and clinical presentation.
  • Verapamil and diltiazem are effective in improving LV diastolic function and filling patterns in HCM.
  • Targeting diastolic dysfunction with specific calcium channel blockers offers therapeutic potential for HCM patients.